Lantheus Biosciences Ltd.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Previously recorded as Life Molecular Imaging Limited (to 2026)
4
Ending by 2030
Oct 2028
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Oct 12 to 19, 2027 · next Oct 12
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,266,506 | Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors In force · From the USPTO record | In force | From the USPTO record | |
| US 8,557,776 | Compounds and Methods for 18F Labeled Agents In force · High confidence | In force | High confidence | |
| US 9,682,944 | Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors In force · From the USPTO record | In force | From the USPTO record | |
| US 8,784,775 | Compounds for Use in Imaging, Diagnosing And/Or Treatment of Diseases of the Central Nervous System or of Tumors In force · High confidence | In force | High confidence | |
| US 8,968,701 | Usage of low to medium-pressure liquid chromatography for the purification of radiotracers In force · High confidence | In force | High confidence | |
| US 9,592,308 | Method for production of F-18 labeled amyloid beta ligands In force · From the USPTO record | In force | From the USPTO record | |
| US 8,981,156 | Method for Production of F-18 Labeled Amyloid Beta Ligands In force · Medium confidence | In force | Medium confidence | |
| US 9,314,540 | Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system In force · From the USPTO record | In force | From the USPTO record | |
| US 9,308,284 | Formulations of fluorinated stilbene suitable for PET imaging In force · From the USPTO record | In force | From the USPTO record | |
| US 9,744,252 | Compounds for binding to the platelet specific glycoprotein IIb/IIIa and their use for imaging of thrombi In force · From the USPTO record | In force | From the USPTO record |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.